# MAP3K20

## Overview
MAP3K20 is a gene that encodes the protein mitogen-activated protein kinase kinase kinase 20, a member of the serine/threonine kinase family involved in signal transduction pathways. This protein plays a pivotal role in cellular processes such as growth, differentiation, and apoptosis by participating in the activation of key signaling pathways, including the JNK/SAPK and NF-κB pathways (Liu2000Cloning). The MAP3K20 gene produces two isoforms, with distinct expression patterns and functional roles, particularly in muscle tissues (Vasli2016Recessive; Ahmad2022A). The protein's involvement in various signaling pathways underscores its significance in both normal cellular functions and pathological conditions, including cancer, where its expression levels can influence disease outcomes (Nguyen2022MAP3K).

## Structure
The MAP3K20 gene, also known as ZAK, encodes a protein that is part of the mitogen-activated protein triple kinase (MAP3K) family, involved in signal transduction. The protein features an N-terminal kinase domain encoded by exons 2-9, which is crucial for its enzymatic activity (Ahmad2022A). Following the kinase domain, the protein includes two dimerization domains: a leucine-zipper motif and a sterile-alpha motif (SAM) (Ahmad2022A). 

MAP3K20 produces two isoforms. Isoform 1 is 800 amino acids long and is expressed in various tissues, while isoform 2 is 455 amino acids long and is predominantly expressed in skeletal muscle and the heart. These isoforms are identical except that isoform 2 differs in the 3'UTR and does not encode the SAM domain (Ahmad2022A). 

The protein is classified within the TKL group of kinases, consistent with previous classifications (Modi2019A). The molecular structure of MAP3K20 is not directly discussed in the sources, but its classification within the TKL group suggests it shares structural features common to this group, such as specific folds and motifs typical of serine/threonine kinases. I cannot provide further details on the tertiary or quaternary structure due to insufficient information.

## Function
MAP3K20, also known as ZAK, is a member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, which plays a crucial role in signal transduction pathways. This gene encodes a protein that functions as a serine/threonine kinase, involved in regulating various cellular processes such as cell growth, differentiation, and apoptosis (Liu2000Cloning). MAP3K20 is active in both the cytoplasm and nucleus, where it influences cellular homeostasis by transmitting extracellular signals into appropriate cellular responses (Liu2000Cloning).

The protein encoded by MAP3K20 is involved in the activation of the JNK/SAPK pathway, which is important for stress responses and apoptosis (Liu2000Cloning). It also activates the transcription factor NF-B, which is involved in immune and inflammatory responses (Liu2000Cloning). MAP3K20 is expressed in various tissues, with higher expression levels in skeletal muscle and heart, particularly the shorter isoform 2, which lacks the sterile-alpha motif (SAM) domain (Vasli2016Recessive; Ahmad2022A). The differential expression of MAP3K20 isoforms suggests distinct roles in muscle physiology and pathology, contributing to muscle development and regeneration (Vasli2016Recessive).

## Clinical Significance
MAP3K20, a member of the MAP3K family, plays a significant role in various cancer types due to its involvement in the ERK and JNK signaling pathways. Alterations in the expression of MAP3K20 have been linked to different cancer outcomes. For instance, certain isoforms of MAP3K20 are positively correlated with the development of gastric and colorectal cancers, while others promote apoptosis in osteosarcoma, suggesting an anti-tumor role (Nguyen2022MAP3K). In esophageal squamous cell carcinoma and sarcoma, higher mRNA expression of MAP3K20 is associated with increased survival, indicating a potential protective effect (Nguyen2022MAP3K). Conversely, its expression is negatively associated with survival in cervical squamous cell carcinoma, kidney renal papillary cell carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, and pancreatic ductal adenocarcinoma, suggesting a detrimental role in these cancers (Nguyen2022MAP3K).

In bladder cancer, MAP3K20 is significantly downregulated in tumor tissues compared to normal tissues, as shown by immunohistochemical analysis and qRT-PCR validation. This downregulation may influence tumor-associated metabolic processes and immune system activities, highlighting its potential as a therapeutic target (Cheng2024Predicting).


## References


[1. (Vasli2016Recessive) Nasim Vasli, Elizabeth Harris, Jason Karamchandani, Eric Bareke, Jacek Majewski, Norma B. Romero, Tanya Stojkovic, Rita Barresi, Hichem Tasfaout, Richard Charlton, Edoardo Malfatti, Johann Bohm, Chiara Marini-Bettolo, Karine Choquet, Marie-Josée Dicaire, Yi-Hong Shao, Ana Topf, Erin O’Ferrall, Bruno Eymard, Volker Straub, Gonzalo Blanco, Hanns Lochmüller, Bernard Brais, Jocelyn Laporte, and Martine Tétreault. Recessive mutations in the kinase zak cause a congenital myopathy with fibre type disproportion. Brain, 140(1):37–48, November 2016. URL: http://dx.doi.org/10.1093/brain/aww257, doi:10.1093/brain/aww257. This article has 28 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/aww257)

[2. (Cheng2024Predicting) Guangyang Cheng, Zhaokai Zhou, Shiqi Li, Shuai Yang, Yan Wang, Zhuo Ye, and Chuanchuan Ren. Predicting bladder cancer survival with high accuracy: insights from mapk pathway-related genes. Scientific Reports, May 2024. URL: http://dx.doi.org/10.1038/s41598-024-61302-0, doi:10.1038/s41598-024-61302-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-61302-0)

[3. (Liu2000Cloning) Te-Chung Liu, Chang-Jen Huang, Yu-Chuan Chu, Chih-Chang Wei, Chun-Chieh Chou, Ming-Yung Chou, Chen-Kung Chou, and Jaw-Ji Yang. Cloning and expression of zak, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. Biochemical and Biophysical Research Communications, 274(3):811–816, August 2000. URL: http://dx.doi.org/10.1006/bbrc.2000.3236, doi:10.1006/bbrc.2000.3236. This article has 82 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/bbrc.2000.3236)

[4. (Ahmad2022A) Ilyas Ahmad, Ayaz Khan, Hafiza Noor Ul Ayan, Birgit Budde, Janine Altmüller, Asad Aslam Korejo, Gudrun Nürnberg, Holger Thiele, Muhmmad Tariq, Peter Nürnberg, and Jeanette Erdmann. A novel map3k20 mutation causing centronuclear myopathy-6 with fiber-type disproportion in a pakistani family. Journal of Human Genetics, 68(2):107–109, October 2022. URL: http://dx.doi.org/10.1038/s10038-022-01085-2, doi:10.1038/s10038-022-01085-2. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s10038-022-01085-2)

[5. (Nguyen2022MAP3K) Khoa Nguyen, Minh N. Tran, Andrew Rivera, Thomas Cheng, Gabrielle O. Windsor, Abraham B. Chabot, Jane E. Cavanaugh, Bridgette M. Collins-Burow, Sean B. Lee, David H. Drewry, Patrick T. Flaherty, and Matthew E. Burow. Map3k family review and correlations with patient survival outcomes in various cancer types. Frontiers in Bioscience-Landmark, 27(5):167, May 2022. URL: http://dx.doi.org/10.31083/j.fbl2705167, doi:10.31083/j.fbl2705167. This article has 11 citations.](https://doi.org/10.31083/j.fbl2705167)

[6. (Modi2019A) Vivek Modi and Roland L. Dunbrack. A structurally-validated multiple sequence alignment of 497 human protein kinase domains. Scientific Reports, December 2019. URL: http://dx.doi.org/10.1038/s41598-019-56499-4, doi:10.1038/s41598-019-56499-4. This article has 93 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-56499-4)